LCMS webinars focusing on LC/HRMS | LabRulez LCMS

Enhancing the characterization of mRNA lipid nanoparticle drugs and vaccines with new LC-MS solutions

Discover how a quadrupole time-of-flight (QTOF) system can be used for high-resolution quantitation of oligonucleotides.

Chapter 3: Inside the technical note

Join us for a live event that will take you behind the scenes of technotes. Get ready to ignite your curiosity and expand your knowledge in this unique webinar experience.

Make Metabolomics library building easier with intelligent data acquisition and curation software

Join us for a webinar, where metabolomics experts will demonstrate how to use our mass spectral library curation software, Thermo Scientific™ mzVault™ library and Thermo Scientific™ Mass Frontier™ with curator.

Accurate mass workflows for PFAS in food using the ZenoTOF 7600 system

High-sensitivity workflows for screening and quantitation with precise confirmation, using the ZenoTOF 7600 system.

Preparing your Lab for the holiday season

Join our webinar and learn some easy protocols to prepare your analytical instruments to be switched off and some best practices around HPLC columns conditioning.

What Do You Get from Ion Mobility Q-TOF?

Data generated with the IMQTOF and how it can help solve challenges in screening and discovery.

Rapid food and feed analysis through VOC analysis using SICRIT technology

Recent work undertaking using SICRIT technology for both targeted and untargeted food and feed monitoring tasks.

Empowering single cell proteomics with Orbitrap Astral

The initial session is Orbitrap Astral: Enabling Single Cell Proteomics.

How mass spectrometry innovation propels biological discovery

This webcast will highlight how new methodologies using mass spectrometry enable deep proteome sequencing and population-scale biological discovery.

Rational Design of a New Generation of Therapeutic Oligonucleotide Tools

This webinar will present new chemically modified oligonucleotide tools with the potential to tackle multifactorial disorders while overcoming the limitations of oligonucleotide therapeutics.